NIRMATRELVIR AND RITONAVIR

NIRMATRELVIR AND RITONAVIR was reported 53956 times

These side effects are most commonly reported by patients taking NIRMATRELVIR AND RITONAVIR:

# Side effect Count
0 COVID-19 22833
1 DISEASE RECURRENCE 20106
2 DYSGEUSIA 7364
3 DIARRHOEA 4041
4 NAUSEA 2646
5 HEADACHE 2182
6 COUGH 2051
7 FATIGUE 2016
8 INCORRECT DOSE ADMINISTERED 1722
9 VOMITING 1413
10 MALAISE 1380
11 NASAL CONGESTION 1368
12 OFF LABEL USE 1325
13 DRUG INTERACTION 1305
14 PYREXIA 1256
15 OROPHARYNGEAL PAIN 1251
16 DIZZINESS 1206
17 RHINORRHOEA 1091
18 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1082
19 PAIN 1065
20 TASTE DISORDER 1049
21 SYMPTOM RECURRENCE 994
22 PRODUCT PRESCRIBING ERROR 973
23 FEELING ABNORMAL 970
24 INSOMNIA 871
25 ILLNESS 835
26 ABDOMINAL PAIN UPPER 815
27 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 759
28 DYSPNOEA 751
29 RASH 750
30 INCORRECT PRODUCT ADMINISTRATION DURATION 737
31 ASTHENIA 710
32 CONTRAINDICATED PRODUCT ADMINISTERED 676
33 ABDOMINAL DISCOMFORT 667
34 DECREASED APPETITE 638
35 SARS-COV-2 TEST POSITIVE 630
36 PRODUCT USE ISSUE 619
37 PRURITUS 576
38 PRODUCT TASTE ABNORMAL 566
39 MYALGIA 513
40 NASOPHARYNGITIS 508
41 ABDOMINAL PAIN 504
42 DRUG INEFFECTIVE 483
43 SNEEZING 478
44 URTICARIA 461
45 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 455
46 CONDITION AGGRAVATED 441
47 CHILLS 410
48 HYPERTENSION 408
49 PRODUCT DOSE OMISSION ISSUE 406
50 DYSPHAGIA 398
51 DRY MOUTH 389
52 ACUTE KIDNEY INJURY 374
53 DYSPHONIA 368
54 AGEUSIA 364
55 THERAPEUTIC RESPONSE UNEXPECTED 361
56 REBOUND EFFECT 342
57 INTENTIONAL PRODUCT MISUSE 337
58 ARTHRALGIA 336
59 WEIGHT DECREASED 332
60 BLOOD PRESSURE INCREASED 317
61 MUSCLE SPASMS 315
62 PRODUCT DISPENSING ERROR 310
63 HYPERHIDROSIS 308
64 ANXIETY 298
65 TOXICITY TO VARIOUS AGENTS 294
66 CHEST DISCOMFORT 290
67 HYPERSENSITIVITY 289
68 CHEST PAIN 287
69 DEHYDRATION 283
70 DYSPEPSIA 279
71 BACK PAIN 277
72 TREMOR 277
73 PAIN IN EXTREMITY 266
74 THROAT IRRITATION 258
75 PRODUCT USE COMPLAINT 254
76 PALPITATIONS 244
77 HYPOTENSION 236
78 EXPIRED PRODUCT ADMINISTERED 234
79 ANOSMIA 230
80 PRODUCTIVE COUGH 230
81 SOMNOLENCE 230
82 ERYTHEMA 229
83 DRUG HYPERSENSITIVITY 220
84 PNEUMONIA 220
85 SINUSITIS 217
86 DEATH 208
87 CONFUSIONAL STATE 206
88 HEART RATE INCREASED 206
89 GASTROINTESTINAL DISORDER 205
90 FALL 204
91 GASTROOESOPHAGEAL REFLUX DISEASE 198
92 PARAESTHESIA 195
93 BRADYCARDIA 193
94 THROAT TIGHTNESS 193
95 VISION BLURRED 192
96 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 190
97 SINUS CONGESTION 188
98 CONSTIPATION 185
99 LOSS OF CONSCIOUSNESS 183
100 GAIT DISTURBANCE 181
101 SYNCOPE 176
102 HYPOAESTHESIA 172
103 DRUG LEVEL INCREASED 166
104 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 165
105 TINNITUS 158
106 RESPIRATORY TRACT CONGESTION 156
107 LIP SWELLING 155
108 ASTHMA 151
109 BURNING SENSATION 148
110 PRODUCT PRESCRIBING ISSUE 148
111 PRODUCT SIZE ISSUE 147
112 MIGRAINE 143
113 VERTIGO 143
114 SLEEP DISORDER 140
115 HAEMATOCHEZIA 137
116 FAECES DISCOLOURED 136
117 MUSCULAR WEAKNESS 135
118 UPPER RESPIRATORY TRACT CONGESTION 135
119 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 134
120 FEEDING DISORDER 131
121 HYPONATRAEMIA 131
122 ABDOMINAL DISTENSION 130
123 BLOOD GLUCOSE INCREASED 130
124 CONTRAINDICATED PRODUCT PRESCRIBED 130
125 SWOLLEN TONGUE 130
126 HALLUCINATION 129
127 BALANCE DISORDER 128
128 RASH PRURITIC 128
129 FEELING HOT 126
130 DISCOMFORT 125
131 HEART RATE DECREASED 125
132 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 125
133 FLATULENCE 123
134 MATERNAL EXPOSURE DURING PREGNANCY 123
135 SWELLING FACE 123
136 URINARY TRACT INFECTION 122
137 CHROMATURIA 118
138 PERIPHERAL SWELLING 118
139 RENAL IMPAIRMENT 118
140 RETCHING 116
141 PHARYNGEAL SWELLING 115
142 NERVOUSNESS 111
143 OXYGEN SATURATION DECREASED 110
144 MEMORY IMPAIRMENT 109
145 POOR QUALITY PRODUCT ADMINISTERED 109
146 NIGHT SWEATS 108
147 THERAPY CESSATION 108
148 SPEECH DISORDER 107
149 VISUAL IMPAIRMENT 107
150 BLOOD PRESSURE DECREASED 106
151 BRAIN FOG 106
152 RASH ERYTHEMATOUS 105
153 ACCIDENTAL OVERDOSE 103
154 DEPRESSION 101
155 EAR PAIN 100
156 BRONCHITIS 99
157 LETHARGY 98
158 PRODUCT PACKAGING QUANTITY ISSUE 97
159 OVERDOSE 96
160 ATRIAL FIBRILLATION 94
161 BLOOD CREATININE INCREASED 93
162 HEAD DISCOMFORT 92
163 TACHYCARDIA 92
164 GASTRIC DISORDER 91
165 EPISTAXIS 89
166 STOMATITIS 89
167 PRODUCT LABEL CONFUSION 88
168 UPPER-AIRWAY COUGH SYNDROME 88
169 SWELLING 87
170 RECTAL HAEMORRHAGE 86
171 LYMPHADENOPATHY 85
172 INFLUENZA LIKE ILLNESS 84
173 PAROSMIA 84
174 POST-ACUTE COVID-19 SYNDROME 84
175 PRESYNCOPE 84
176 BLISTER 83
177 DISORIENTATION 82
178 NECK PAIN 82
179 ORAL DISCOMFORT 82
180 INFECTION 81
181 INFLUENZA 81
182 POOR QUALITY SLEEP 81
183 PARAESTHESIA ORAL 80
184 RENAL FAILURE 79
185 HYPOAESTHESIA ORAL 78
186 POLLAKIURIA 78
187 HAEMORRHAGE 76
188 HYPOACUSIS 76
189 PRODUCT USE IN UNAPPROVED INDICATION 76
190 MIDDLE INSOMNIA 74
191 DISTURBANCE IN ATTENTION 73
192 HOT FLUSH 73
193 ORAL PAIN 73
194 SARS-COV-2 TEST NEGATIVE 73
195 SINUS DISORDER 73
196 COLD SWEAT 72
197 ALANINE AMINOTRANSFERASE INCREASED 71
198 COVID-19 PNEUMONIA 71
199 DYSSTASIA 71
200 EATING DISORDER 71
201 PRODUCT COMMUNICATION ISSUE 71
202 ASYMPTOMATIC COVID-19 70
203 DIARRHOEA HAEMORRHAGIC 70
204 NEUTROPENIA 70
205 OROPHARYNGEAL DISCOMFORT 70
206 PARANASAL SINUS DISCOMFORT 70
207 SEIZURE 70
208 APHONIA 69
209 GAIT INABILITY 69
210 THERAPY INTERRUPTED 69
211 EAR DISCOMFORT 68
212 EYE PAIN 67
213 FAECES PALE 67
214 GLOSSODYNIA 67
215 NIGHTMARE 67
216 GASTROINTESTINAL PAIN 66
217 DRY THROAT 65
218 LACRIMATION INCREASED 65
219 AGITATION 64
220 RENAL PAIN 64
221 CARDIAC DISORDER 63
222 CEREBROVASCULAR ACCIDENT 63
223 FLUSHING 63
224 PRODUCT ADMINISTRATION ERROR 63
225 BODY TEMPERATURE INCREASED 62
226 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 60
227 MUSCULOSKELETAL STIFFNESS 60
228 HYPERSOMNIA 59
229 PRODUCT PACKAGING CONFUSION 59
230 SKIN EXFOLIATION 59
231 ABNORMAL DREAMS 58
232 INTENTIONAL DOSE OMISSION 58
233 RASH MACULAR 58
234 SECRETION DISCHARGE 58
235 EYE IRRITATION 57
236 INTENTIONAL PRODUCT USE ISSUE 57
237 PRODUCT PACKAGING ISSUE 57
238 UPPER RESPIRATORY TRACT INFECTION 57
239 WHEEZING 57
240 ASPARTATE AMINOTRANSFERASE INCREASED 56
241 RENAL DISORDER 56
242 RESPIRATORY DISORDER 56
243 CONTUSION 55
244 ERUCTATION 55
245 HEPATIC ENZYME INCREASED 55
246 JOINT SWELLING 55
247 ANORECTAL DISCOMFORT 54
248 HYPOPHAGIA 53
249 NO ADVERSE EVENT 53
250 PANIC ATTACK 53
251 TONGUE DISORDER 53
252 WEIGHT INCREASED 53
253 MOBILITY DECREASED 52
254 THIRST 52
255 DELIRIUM 50
256 EYE PRURITUS 50
257 RESTLESSNESS 50
258 THINKING ABNORMAL 50
259 TONGUE DISCOMFORT 50
260 ANAEMIA 49
261 ARRHYTHMIA 49
262 DYSURIA 49
263 LIVER DISORDER 49
264 NEUROPATHY PERIPHERAL 49
265 ANAPHYLACTIC REACTION 48
266 LUNG DISORDER 48
267 MENTAL DISORDER 48
268 SINUS PAIN 48
269 ADVERSE DRUG REACTION 47
270 ALOPECIA 47
271 ENCEPHALOPATHY 47
272 GENERAL PHYSICAL HEALTH DETERIORATION 47
273 PANCREATITIS 47
274 TONGUE DISCOLOURATION 47
275 DYSPNOEA EXERTIONAL 46
276 MOUTH SWELLING 46
277 RESTLESS LEGS SYNDROME 46
278 CHOKING 45
279 FEELING COLD 45
280 ORAL HERPES 45
281 PRODUCT DOSE OMISSION IN ERROR 45
282 URINARY RETENTION 45
283 ANGIOEDEMA 44
284 BLOOD SODIUM DECREASED 44
285 DYSCHEZIA 44
286 EYE SWELLING 44
287 INTERCEPTED PRODUCT PRESCRIBING ERROR 44
288 OCULAR HYPERAEMIA 44
289 PRODUCT LABEL ISSUE 44
290 EXTRA DOSE ADMINISTERED 43
291 HYPERKALAEMIA 43
292 MENTAL STATUS CHANGES 43
293 THROMBOCYTOPENIA 43
294 THROMBOSIS 43
295 TOOTHACHE 43
296 COGNITIVE DISORDER 42
297 DRUG INTOLERANCE 42
298 MOVEMENT DISORDER 42
299 RESPIRATORY FAILURE 42
300 WHITE BLOOD CELL COUNT DECREASED 42
301 ABDOMINAL PAIN LOWER 41
302 AMNESIA 41
303 CRYING 41
304 IRRITABILITY 41
305 PROCTALGIA 41
306 DRY SKIN 40
307 FREQUENT BOWEL MOVEMENTS 40
308 HALLUCINATION, VISUAL 40
309 LABELLED DRUG-DRUG INTERACTION ISSUE 40
310 RASH PAPULAR 40
311 WHITE BLOOD CELL COUNT INCREASED 40
312 HAEMOPTYSIS 39
313 HAEMORRHOIDS 39
314 MUSCLE TIGHTNESS 39
315 ORAL MUCOSAL BLISTERING 39
316 PRODUCT BLISTER PACKAGING ISSUE 39
317 SKIN DISCOLOURATION 39
318 TONGUE COATED 39
319 DIABETES MELLITUS 38
320 EAR INFECTION 38
321 FEELING JITTERY 38
322 HAEMOGLOBIN DECREASED 38
323 INFUSION RELATED REACTION 38
324 LIMB DISCOMFORT 38
325 SUSPECTED COVID-19 38
326 DEAFNESS 37
327 EYE DISORDER 37
328 INCORRECT DOSAGE ADMINISTERED 37
329 MYOCARDIAL INFARCTION 37
330 PULMONARY CONGESTION 37
331 BLOOD GLUCOSE DECREASED 36
332 HEPATIC CYTOLYSIS 36
333 HERPES ZOSTER 36
334 LARYNGITIS 36
335 NEAR DEATH EXPERIENCE 36
336 PULMONARY EMBOLISM 36
337 BLOOD URINE PRESENT 35
338 CARDIAC ARREST 35
339 FAECES SOFT 35
340 GASTROINTESTINAL HAEMORRHAGE 35
341 HEART RATE IRREGULAR 35
342 HYPOXIA 35
343 NEURALGIA 35
344 RHABDOMYOLYSIS 35
345 SEPSIS 35
346 ABNORMAL FAECES 34
347 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34
348 HAEMATEMESIS 34
349 HEPATIC FUNCTION ABNORMAL 34
350 LIVER FUNCTION TEST INCREASED 34
351 MENTAL IMPAIRMENT 34
352 MUSCULOSKELETAL CHEST PAIN 34
353 RHEUMATOID ARTHRITIS 34
354 COLITIS 33
355 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33
356 NASAL DISCOMFORT 33
357 PLATELET COUNT DECREASED 33
358 SEROTONIN SYNDROME 33
359 UNDERDOSE 33
360 URINARY INCONTINENCE 33
361 ARTHRITIS 32
362 BLOOD POTASSIUM DECREASED 32
363 CARDIAC FAILURE 32
364 CORONAVIRUS TEST POSITIVE 32
365 DRUG LEVEL ABOVE THERAPEUTIC 32
366 ELECTROCARDIOGRAM QT PROLONGED 32
367 HEAD INJURY 32
368 IMMUNE SYSTEM DISORDER 32
369 MOUTH ULCERATION 32
370 PAIN IN JAW 32
371 SKIN BURNING SENSATION 32
372 SPUTUM DISCOLOURED 32
373 SUICIDAL IDEATION 32
374 CONJUNCTIVITIS 31
375 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 31
376 EXPOSURE DURING PREGNANCY 31
377 HYPOKALAEMIA 31
378 INFLAMMATION 31
379 IRRITABLE BOWEL SYNDROME 31
380 METABOLIC ACIDOSIS 31
381 PARANASAL SINUS HYPERSECRETION 31
382 SINUS HEADACHE 31
383 STRESS 31
384 THROMBOTIC MICROANGIOPATHY 31
385 BLOOD PRESSURE SYSTOLIC INCREASED 30
386 BONE PAIN 30
387 ENERGY INCREASED 30
388 HICCUPS 30
389 INITIAL INSOMNIA 30
390 NEPHROLITHIASIS 30
391 ODYNOPHAGIA 30
392 ORAL DISORDER 30
393 SALIVARY HYPERSECRETION 30
394 SENSATION OF FOREIGN BODY 30
395 STEVENS-JOHNSON SYNDROME 30
396 SUSPECTED OFF LABEL USE 30
397 BLOOD PRESSURE ABNORMAL 29
398 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 29
399 DRY EYE 29
400 FEAR 29
401 LIVER INJURY 29
402 MULTIPLE SCLEROSIS 29
403 OEDEMA PERIPHERAL 29
404 ORAL CANDIDIASIS 29
405 PRODUCT AFTER TASTE 29
406 SEASONAL ALLERGY 29
407 BREATH ODOUR 28
408 CARDIOGENIC SHOCK 28
409 DIVERTICULITIS 28
410 DRUG-INDUCED LIVER INJURY 28
411 JAUNDICE 28
412 MUSCLE TWITCHING 28
413 MUSCULOSKELETAL DISCOMFORT 28
414 PRODUCT DISPENSING ISSUE 28
415 BLOOD CREATINE PHOSPHOKINASE INCREASED 27
416 BODY TEMPERATURE DECREASED 27
417 DISEASE PROGRESSION 27
418 IMPAIRED QUALITY OF LIFE 27
419 INJECTION SITE PAIN 27
420 RESPIRATORY SYMPTOM 27
421 BLOOD PRESSURE FLUCTUATION 26
422 EUPHORIC MOOD 26
423 FACIAL PAIN 26
424 FOREIGN BODY IN THROAT 26
425 HEPATIC PAIN 26
426 NEUROTOXICITY 26
427 PRODUCT PHYSICAL ISSUE 26
428 PRODUCT STORAGE ERROR 26
429 SKIN DISORDER 26
430 ANAL INCONTINENCE 25
431 BLOOD UREA INCREASED 25
432 C-REACTIVE PROTEIN INCREASED 25
433 DIPLOPIA 25
434 DIZZINESS POSTURAL 25
435 ECZEMA 25
436 EMOTIONAL DISORDER 25
437 GASTRITIS 25
438 GINGIVAL BLEEDING 25
439 HEPATITIS 25
440 MELAENA 25
441 PANCYTOPENIA 25
442 PANIC REACTION 25
443 TRANSAMINASES INCREASED 25
444 VOMITING PROJECTILE 25
445 WRONG PRODUCT ADMINISTERED 25
446 DYSARTHRIA 24
447 DYSKINESIA 24
448 LACTIC ACIDOSIS 24
449 OESOPHAGEAL PAIN 24
450 PHOTOPHOBIA 24
451 PLEURAL EFFUSION 24
452 SEPTIC SHOCK 24
453 APHASIA 23
454 ARTHROPATHY 23
455 BLOOD CHOLESTEROL INCREASED 23
456 DEPRESSED MOOD 23
457 GLOMERULAR FILTRATION RATE DECREASED 23
458 HYPERTENSIVE CRISIS 23
459 IMMUNODEFICIENCY 23
460 INTERNATIONAL NORMALISED RATIO INCREASED 23
461 PANCREATITIS ACUTE 23
462 PHOTOSENSITIVITY REACTION 23
463 PRODUCT ADMINISTRATION INTERRUPTED 23
464 PRODUCT COLOUR ISSUE 23
465 PSORIASIS 23
466 RASH MACULO-PAPULAR 23
467 URINE OUTPUT DECREASED 23
468 ACNE 22
469 APPETITE DISORDER 22
470 BLINDNESS 22
471 DEPRESSED LEVEL OF CONSCIOUSNESS 22
472 FUNGAL INFECTION 22
473 HYPERGLYCAEMIA 22
474 LOWER RESPIRATORY TRACT INFECTION 22
475 PSYCHOMOTOR HYPERACTIVITY 22
476 PULMONARY PAIN 22
477 SENSORY DISTURBANCE 22
478 ACUTE HEPATIC FAILURE 21
479 ANGER 21
480 HALLUCINATION, AUDITORY 21
481 HOSPITALISATION 21
482 LIP BLISTER 21
483 PALLOR 21
484 PRODUCT EXPIRATION DATE ISSUE 21
485 RHINITIS 21
486 TONGUE ERYTHEMA 21
487 ALTERED STATE OF CONSCIOUSNESS 20
488 ANGINA PECTORIS 20
489 BLOOD ALKALINE PHOSPHATASE INCREASED 20
490 BOWEL MOVEMENT IRREGULARITY 20
491 CANDIDA INFECTION 20
492 COMA 20
493 EMOTIONAL DISTRESS 20
494 FEBRILE NEUTROPENIA 20
495 GINGIVAL PAIN 20
496 NEOPLASM MALIGNANT 20
497 NEPHROPATHY TOXIC 20
498 PHARYNGEAL DISORDER 20
499 PSYCHOTIC DISORDER 20
500 RED BLOOD CELL COUNT DECREASED 20
501 RESPIRATORY TRACT INFECTION 20
502 YELLOW SKIN 20
503 ANAL HAEMORRHAGE 19
504 ATRIOVENTRICULAR BLOCK COMPLETE 19
505 BODY HEIGHT DECREASED 19
506 CHOLELITHIASIS 19
507 CHRONIC KIDNEY DISEASE 19
508 CIRCULATORY COLLAPSE 19
509 CROHN^S DISEASE 19
510 CYSTITIS 19
511 DRUG ERUPTION 19
512 FLUID RETENTION 19
513 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 19
514 INTERCEPTED PRODUCT DISPENSING ERROR 19
515 PARANOIA 19
516 PERIPHERAL COLDNESS 19
517 PNEUMONIA BACTERIAL 19
518 SWELLING OF EYELID 19
519 UNEVALUABLE EVENT 19
520 WRONG DOSE 19
521 BEDRIDDEN 18
522 CARDIAC FAILURE CONGESTIVE 18
523 CORONAVIRUS INFECTION 18
524 EAR CONGESTION 18
525 GLOSSITIS 18
526 HYPERAESTHESIA 18
527 IMPAIRED GASTRIC EMPTYING 18
528 LIPASE INCREASED 18
529 MUSCULOSKELETAL PAIN 18
530 NERVOUS SYSTEM DISORDER 18
531 NEUTROPHIL COUNT DECREASED 18
532 PERIORBITAL SWELLING 18
533 PNEUMONIA ASPIRATION 18
534 SHOCK 18
535 SLUGGISHNESS 18
536 SUSPECTED COUNTERFEIT PRODUCT 18
537 TONGUE BLISTERING 18
538 DEAFNESS UNILATERAL 17
539 DEEP VEIN THROMBOSIS 17
540 DERMATITIS ALLERGIC 17
541 GOUT 17
542 HAEMATURIA 17
543 HEAVY MENSTRUAL BLEEDING 17
544 HYPOTHERMIA 17
545 LIMB INJURY 17
546 LIP PAIN 17
547 LIVER FUNCTION TEST ABNORMAL 17
548 MUSCLE DISORDER 17
549 NASAL DRYNESS 17
550 PRODUCT DOSE CONFUSION 17
551 PULMONARY FIBROSIS 17
552 SINUS BRADYCARDIA 17
553 TREATMENT NONCOMPLIANCE 17
554 UNRESPONSIVE TO STIMULI 17
555 VIRAL INFECTION 17
556 AGGRESSION 16
557 DEMENTIA 16
558 DIABETIC KETOACIDOSIS 16
559 EYE INFECTION 16
560 FLANK PAIN 16
561 GINGIVAL SWELLING 16
562 MANIA 16
563 OCULAR DISCOMFORT 16
564 PAIN OF SKIN 16
565 PARALYSIS 16
566 PULMONARY OEDEMA 16
567 RESPIRATORY DISTRESS 16
568 THERAPEUTIC PRODUCT EFFECT DECREASED 16
569 TRANSIENT ISCHAEMIC ATTACK 16
570 VAGINAL HAEMORRHAGE 16
571 AGRANULOCYTOSIS 15
572 AUTOIMMUNE DISORDER 15
573 BACTERIAL INFECTION 15
574 CATARACT 15
575 CHEILITIS 15
576 ELECTROLYTE IMBALANCE 15
577 EYE HAEMORRHAGE 15
578 FIBRIN D DIMER INCREASED 15
579 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15
580 HAEMORRHOIDAL HAEMORRHAGE 15
581 IMMUNOSUPPRESSION 15
582 LEUKOPENIA 15
583 MEDICATION ERROR 15
584 MICTURITION URGENCY 15
585 NASAL DISORDER 15
586 OCULAR ICTERUS 15
587 ORTHOSTATIC HYPOTENSION 15
588 PHARYNGITIS STREPTOCOCCAL 15
589 POOR VENOUS ACCESS 15
590 POTENTIATING DRUG INTERACTION 15
591 PRODUCT COMPLAINT 15
592 REACTION TO EXCIPIENT 15
593 SLEEP APNOEA SYNDROME 15
594 SYSTEMIC LUPUS ERYTHEMATOSUS 15
595 WITHDRAWAL SYNDROME 15
596 APHTHOUS ULCER 14
597 BREAST PAIN 14
598 COAGULOPATHY 14
599 COLITIS ULCERATIVE 14
600 DELUSION 14
601 DYSENTERY 14
602 EYE DISCHARGE 14
603 FEELING OF BODY TEMPERATURE CHANGE 14
604 GASTROINTESTINAL SOUNDS ABNORMAL 14
605 HAEMATOCRIT DECREASED 14
606 HIP FRACTURE 14
607 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14
608 INJURY 14
609 INTESTINAL OBSTRUCTION 14
610 JOINT STIFFNESS 14
611 LYMPHOCYTE COUNT DECREASED 14
612 MENSTRUATION IRREGULAR 14
613 MOOD ALTERED 14
614 NONSPECIFIC REACTION 14
615 OEDEMA 14
616 POLYURIA 14
617 POSTMENOPAUSAL HAEMORRHAGE 14
618 PRODUCT CONFUSION 14
619 SCIATICA 14
620 SEDATION 14
621 SKIN IRRITATION 14
622 SKIN WARM 14
623 URINE ODOUR ABNORMAL 14
624 ACUTE MYOCARDIAL INFARCTION 13
625 ADVERSE EVENT 13
626 BACK DISORDER 13
627 BLOOD BILIRUBIN INCREASED 13
628 CELLULITIS 13
629 CEREBRAL DISORDER 13
630 HORDEOLUM 13
631 HYPERCHLORHYDRIA 13
632 HYPOGEUSIA 13
633 ILL-DEFINED DISORDER 13
634 IMPAIRED WORK ABILITY 13
635 NEOPLASM PROGRESSION 13
636 OSTEOARTHRITIS 13
637 PHOTOPSIA 13
638 PRODUCT QUALITY ISSUE 13
639 RENAL INJURY 13
640 RHINALGIA 13
641 ACIDOSIS 12
642 ANAPHYLACTIC SHOCK 12
643 ATRIOVENTRICULAR BLOCK 12
644 BLOOD ALBUMIN DECREASED 12
645 BLOOD THYROID STIMULATING HORMONE INCREASED 12
646 CHOKING SENSATION 12
647 DEFAECATION URGENCY 12
648 EAR DISORDER 12
649 EPIGASTRIC DISCOMFORT 12
650 EPILEPSY 12
651 EXPOSURE TO SARS-COV-2 12
652 FEELING DRUNK 12
653 FLUID INTAKE REDUCED 12
654 FOOD ALLERGY 12
655 FORMICATION 12
656 FRUSTRATION TOLERANCE DECREASED 12
657 HEART RATE ABNORMAL 12
658 HEPATIC FAILURE 12
659 HIATUS HERNIA 12
660 INCONTINENCE 12
661 KIDNEY INFECTION 12
662 LIGAMENT SPRAIN 12
663 LIP DRY 12
664 MUCOUS STOOLS 12
665 NOCTURIA 12
666 ORAL PRURITUS 12
667 PNEUMONITIS 12
668 RESPIRATION ABNORMAL 12
669 SINUSITIS BACTERIAL 12
670 SLEEP DEFICIT 12
671 THERAPY NON-RESPONDER 12
672 THERMAL BURN 12
673 TOOTH DISORDER 12
674 TOXIC EPIDERMAL NECROLYSIS 12
675 TRANSCRIPTION MEDICATION ERROR 12
676 VENTRICULAR TACHYCARDIA 12
677 ABNORMAL BEHAVIOUR 11
678 ANORECTAL DISORDER 11
679 BLOOD POTASSIUM INCREASED 11
680 BRONCHOSPASM 11
681 CARDIOVASCULAR DISORDER 11
682 EAR PRURITUS 11
683 EJECTION FRACTION DECREASED 11
684 GENERALISED TONIC-CLONIC SEIZURE 11
685 HEPATIC STEATOSIS 11
686 HUNGER 11
687 HYPOGLYCAEMIA 11
688 HYPOMAGNESAEMIA 11
689 HYPOTHYROIDISM 11
690 INCREASED UPPER AIRWAY SECRETION 11
691 JOINT RANGE OF MOTION DECREASED 11
692 LIP DISORDER 11
693 MUSCLE SPASTICITY 11
694 MUSCLE STRAIN 11
695 NASAL OEDEMA 11
696 OROPHARYNGEAL BLISTERING 11
697 PSORIATIC ARTHROPATHY 11
698 PULMONARY THROMBOSIS 11
699 PULSELESS ELECTRICAL ACTIVITY 11
700 RASH VESICULAR 11
701 SKIN LACERATION 11
702 SKIN REACTION 11
703 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 11
704 SUNBURN 11
705 THERAPEUTIC RESPONSE SHORTENED 11
706 TONGUE DRY 11
707 TROPONIN INCREASED 11
708 VENTRICULAR EXTRASYSTOLES 11
709 ACUTE CORONARY SYNDROME 10
710 APPENDICITIS 10
711 BLOOD LACTATE DEHYDROGENASE INCREASED 10
712 CARDIAC FLUTTER 10
713 DUODENAL ULCER 10
714 FACIAL PARALYSIS 10
715 GASTRIC ULCER 10
716 HAEMOLYSIS 10
717 HEPATITIS ACUTE 10
718 HYPERACUSIS 10
719 HYPOGAMMAGLOBULINAEMIA 10
720 INCOHERENT 10
721 INCREASED APPETITE 10
722 INJECTION SITE ERYTHEMA 10
723 INJECTION SITE REACTION 10
724 LEUKOCYTOSIS 10
725 LYMPH NODE PAIN 10
726 MICTURITION DISORDER 10
727 MYELOSUPPRESSION 10
728 NASAL PRURITUS 10
729 OSTEOPOROSIS 10
730 OXYGEN SATURATION ABNORMAL 10
731 PERICARDITIS 10
732 PHARYNGEAL ERYTHEMA 10
733 POST-TRAUMATIC STRESS DISORDER 10
734 REFLUX GASTRITIS 10
735 REGURGITATION 10
736 SENSITIVE SKIN 10
737 SENSORY LOSS 10
738 SKIN LESION 10
739 SKIN ODOUR ABNORMAL 10
740 SMALL INTESTINAL OBSTRUCTION 10
741 SPINAL PAIN 10
742 TACHYPNOEA 10
743 ARTHROPOD BITE 9
744 BLOOD CHLORIDE DECREASED 9
745 BLOOD IRON DECREASED 9
746 BLOOD PRESSURE DIASTOLIC DECREASED 9
747 BLOOD PRESSURE SYSTOLIC DECREASED 9
748 BLOOD TEST ABNORMAL 9
749 BLOOD TRIGLYCERIDES INCREASED 9
750 BODY TEMPERATURE ABNORMAL 9
751 BREAKTHROUGH COVID-19 9
752 CARDIO-RESPIRATORY ARREST 9
753 CHOLESTASIS 9
754 CYTOPENIA 9
755 DISABILITY 9
756 DRAINAGE 9
757 DRUG RESISTANCE 9
758 EAR SWELLING 9
759 EMPHYSEMA 9
760 FEELING OF DESPAIR 9
761 FIBROMYALGIA 9
762 FUNCTIONAL GASTROINTESTINAL DISORDER 9
763 GUILLAIN-BARRE SYNDROME 9
764 HYPOKINESIA 9
765 ILEUS 9
766 INCREASED TENDENCY TO BRUISE 9
767 INJECTION SITE BRUISING 9
768 KNEE ARTHROPLASTY 9
769 LARYNGEAL OEDEMA 9
770 LIP EXFOLIATION 9
771 LISTLESS 9
772 MIXED LIVER INJURY 9
773 MOOD SWINGS 9
774 MUCOSAL INFLAMMATION 9
775 MULTIPLE SCLEROSIS RELAPSE 9
776 MUSCLE FATIGUE 9
777 PARKINSON^S DISEASE 9
778 PATHOGEN RESISTANCE 9
779 POISONING 9
780 PRE-EXISTING CONDITION IMPROVED 9
781 PRODUCT AVAILABILITY ISSUE 9
782 PRODUCT ODOUR ABNORMAL 9
783 ROAD TRAFFIC ACCIDENT 9
784 ROSACEA 9
785 SCAR 9
786 SCREAMING 9
787 SINUS NODE DYSFUNCTION 9
788 SJOGREN^S SYNDROME 9
789 SPUTUM INCREASED 9
790 STREPTOCOCCAL INFECTION 9
791 SURGERY 9
792 TACHYPHRENIA 9
793 TEMPERATURE REGULATION DISORDER 9
794 TENSION HEADACHE 9
795 TOXIC ENCEPHALOPATHY 9
796 UPPER LIMB FRACTURE 9
797 URINARY HESITATION 9
798 VITREOUS FLOATERS 9
799 ANAL FISTULA 8
800 ANKYLOSING SPONDYLITIS 8
801 ANURIA 8
802 ASTHENOPIA 8
803 ATAXIA 8
804 BLOOD CREATINE INCREASED 8
805 BLOOD LACTIC ACID INCREASED 8
806 BREATH SOUNDS ABNORMAL 8
807 CEREBRAL HAEMORRHAGE 8
808 CHOLECYSTITIS 8
809 COORDINATION ABNORMAL 8
810 CYANOSIS 8
811 CYTOKINE RELEASE SYNDROME 8
812 DENTAL CARIES 8
813 DISSOCIATION 8
814 DISTRIBUTIVE SHOCK 8
815 DRUG EFFECT LESS THAN EXPECTED 8
816 DRUG WITHDRAWAL SYNDROME 8
817 EYE MOVEMENT DISORDER 8
818 GINGIVAL DISORDER 8
819 HAEMATOMA MUSCLE 8
820 HYPERVENTILATION 8
821 INFUSION SITE DISCHARGE 8
822 INTERNATIONAL NORMALISED RATIO DECREASED 8
823 JOINT INJURY 8
824 LIP ERYTHEMA 8
825 LYMPHOPENIA 8
826 MALIGNANT MELANOMA 8
827 MALNUTRITION 8
828 MAST CELL ACTIVATION SYNDROME 8
829 MONOPLEGIA 8
830 MULTIPLE ALLERGIES 8
831 ORAL MUCOSAL ERUPTION 8
832 OSTEONECROSIS 8
833 PHARYNGEAL ULCERATION 8
834 PLATELET COUNT INCREASED 8
835 PNEUMONIA HAEMOPHILUS 8
836 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 8
837 PROCEDURAL PAIN 8
838 PRODUCT PREPARATION ERROR 8
839 PRODUCT PREPARATION ISSUE 8
840 PROSTATIC DISORDER 8
841 PULMONARY MASS 8
842 SACRAL PAIN 8
843 SARS-COV-2 ANTIBODY TEST POSITIVE 8
844 SHOCK SYMPTOM 8
845 SINUS OPERATION 8
846 SOMNAMBULISM 8
847 TENDERNESS 8
848 TRISMUS 8
849 URINE OUTPUT INCREASED 8
850 ABDOMINAL RIGIDITY 7
851 ACCIDENTAL UNDERDOSE 7
852 ANAL INFLAMMATION 7
853 ANAL PRURITUS 7
854 APTYALISM 7
855 ASPIRATION 7
856 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7
857 BLOOD PRESSURE DIASTOLIC INCREASED 7
858 BLOOD THYROID STIMULATING HORMONE DECREASED 7
859 BRADYKINESIA 7
860 CHAPPED LIPS 7
861 COELIAC DISEASE 7
862 COMPLICATIONS OF TRANSPLANTED KIDNEY 7
863 CONJUNCTIVAL HAEMORRHAGE 7
864 DECREASED IMMUNE RESPONSIVENESS 7
865 DEMENTIA ALZHEIMER^S TYPE 7
866 DERMATITIS 7
867 DERMATITIS CONTACT 7
868 DRUG CLEARANCE DECREASED 7
869 DYSBIOSIS 7
870 DYSMENORRHOEA 7
871 ECONOMIC PROBLEM 7
872 ELECTRIC SHOCK SENSATION 7
873 FACE OEDEMA 7
874 FAECES HARD 7
875 FULL BLOOD COUNT DECREASED 7
876 GASTROINTESTINAL MOTILITY DISORDER 7
877 GENITAL RASH 7
878 GLYCOSURIA 7
879 GLYCOSYLATED HAEMOGLOBIN INCREASED 7
880 HEPATITIS FULMINANT 7
881 HEPATOTOXICITY 7
882 HYPERTENSIVE URGENCY 7
883 HYPERTRANSAMINASAEMIA 7
884 HYPOPHOSPHATAEMIA 7
885 INFUSION SITE PAIN 7
886 INJECTION SITE SWELLING 7
887 INSURANCE ISSUE 7
888 INTERCEPTED PRODUCT ADMINISTRATION ERROR 7
889 INTERMENSTRUAL BLEEDING 7
890 ISCHAEMIC STROKE 7
891 LIP OEDEMA 7
892 LOCALISED INFECTION 7
893 MACULAR DEGENERATION 7
894 MUSCLE ATROPHY 7
895 MYOCARDITIS 7
896 MYOCLONUS 7
897 NERVE INJURY 7
898 NONINFECTIVE GINGIVITIS 7
899 OBSTRUCTIVE AIRWAYS DISORDER 7
900 OESOPHAGEAL DISORDER 7
901 OESOPHAGEAL ULCER 7
902 ORAL MUCOSAL ERYTHEMA 7
903 OSTEOPENIA 7
904 PHARYNGEAL HYPOAESTHESIA 7
905 PHARYNGEAL INFLAMMATION 7
906 PHARYNGEAL OEDEMA 7
907 PHARYNGITIS 7
908 PRODUCT PACKAGING DIFFICULT TO OPEN 7
909 PULSE ABSENT 7
910 PYELONEPHRITIS 7
911 RIB FRACTURE 7
912 ROTATOR CUFF SYNDROME 7
913 SINUS TACHYCARDIA 7
914 SKIN CANCER 7
915 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 7
916 SLEEP TERROR 7
917 SUPRAVENTRICULAR TACHYCARDIA 7
918 SYNDACTYLY 7
919 TONGUE HAEMORRHAGE 7
920 TONSILLITIS 7
921 TREATMENT FAILURE 7
922 UPPER GASTROINTESTINAL HAEMORRHAGE 7
923 VAGINAL DISCHARGE 7
924 ACUTE RESPIRATORY FAILURE 6
925 ACUTE SINUSITIS 6
926 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 6
927 ARTHROPOD STING 6
928 ASPHYXIA 6
929 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6
930 AUDITORY DISORDER 6
931 BLOOD BLISTER 6
932 BLOOD DISORDER 6
933 BLOOD IMMUNOGLOBULIN G DECREASED 6
934 BLOOD MAGNESIUM DECREASED 6
935 BLOOD PHOSPHORUS DECREASED 6
936 BLOOD PRESSURE SYSTOLIC ABNORMAL 6
937 BODY TEMPERATURE FLUCTUATION 6
938 BONE DISORDER 6
939 BRADYPHRENIA 6
940 BRONCHOPULMONARY ASPERGILLOSIS 6
941 BUNDLE BRANCH BLOCK RIGHT 6
942 CARDIOMEGALY 6
943 CARDIOMYOPATHY 6
944 CEREBRAL INFARCTION 6
945 CLOSTRIDIUM DIFFICILE INFECTION 6
946 CONVERSION DISORDER 6
947 CORONARY ARTERY DISEASE 6
948 COUNTERFEIT PRODUCT ADMINISTERED 6
949 DEAFNESS NEUROSENSORY 6
950 DECREASED ACTIVITY 6
951 DERMATITIS ACNEIFORM 6
952 DIALYSIS 6
953 DIVERTICULUM 6
954 DRUG MONITORING PROCEDURE NOT PERFORMED 6
955 DYSGRAPHIA 6
956 DYSTONIA 6
957 EXTRAPYRAMIDAL DISORDER 6
958 EYELID PTOSIS 6
959 FOOD POISONING 6
960 FULL BLOOD COUNT ABNORMAL 6
961 GALLBLADDER DISORDER 6
962 GASTROENTERITIS VIRAL 6
963 GRIP STRENGTH DECREASED 6
964 GROIN PAIN 6
965 HAEMATOMA 6
966 HALLUCINATIONS, MIXED 6
967 HANGOVER 6
968 HEMIPARESIS 6
969 HEPATIC ENCEPHALOPATHY 6
970 HEPATOCELLULAR INJURY 6
971 HERNIA 6
972 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 6
973 HYPERLIPIDAEMIA 6
974 HYPOTENSIVE CRISIS 6
975 ILEUS PARALYTIC 6
976 IMPAIRED DRIVING ABILITY 6
977 INCREASED VISCOSITY OF BRONCHIAL SECRETION 6
978 INFUSION SITE PRURITUS 6
979 INFUSION SITE SWELLING 6
980 INTERCEPTED MEDICATION ERROR 6
981 INTRAOCULAR PRESSURE INCREASED 6
982 LEUKAEMIA 6
983 LEUKOCYTURIA 6
984 MENISCUS INJURY 6
985 MENSTRUATION DELAYED 6
986 MITRAL VALVE INCOMPETENCE 6
987 MUSCLE RUPTURE 6
988 MUSCULOSKELETAL DISORDER 6
989 NASAL DISCHARGE DISCOLOURATION 6
990 NEEDLE ISSUE 6
991 NEUTROPHIL COUNT INCREASED 6
992 OESOPHAGITIS 6
993 PERIPHERAL SENSORY NEUROPATHY 6
994 PHYSICAL DISABILITY 6
995 PHYSICAL PRODUCT LABEL ISSUE 6
996 PLICATED TONGUE 6
997 PRESCRIBED OVERDOSE 6
998 PRODUCT FORMULATION ISSUE 6
999 PRODUCT PHYSICAL CONSISTENCY ISSUE 6